Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/CollabRx+%28CLRX%29+Enters+Molecular+Diagnostics+Partnership+with+Sengenics/8240416.html for the full story.
CollabRx, Inc. (NASDAQ: CLRX) today announced a multi-year partnership
agreement with Life Technologies Corporation for development and
commercialization of CollabRx technology and content resources to be
used in conjunction...
Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, and Genzyme, a Sanofi company (NYSE: SNY), today announced that the New York State Department of Health has issued a license enabling Veracyte's...
Trovagene, Inc. (NASDAQ: TROV), a developer of transrenal molecular diagnostics, today announced that it has received a milestone payment from Ipsogen S.A., a subsidiary of the QIAGEN group. This payment comes from a co-exclusive license...
Investment Underground » Page not foundAug 22Comment
by Chris French
In the past, medical professionals relied mostly on blood tests to determine the presence of life-threatening diseases and conditions in patients as blood contains small pieces of DNA, which clinicians extract from samples...
Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, and Genzyme, a Sanofi company (NYSE: SNY), today announced the publication of new data suggesting that routine clinical use of Veracyte's Afirma®...
TUCSON, AZ -- (Marketwire) -- 07/11/12 -- HTG Molecular Diagnostics, a privately held, Tucson-based developer of mRNA and miRNA gene expression-based cancer diagnostics, has been granted a non-exclusive license to develop, manufacture, and
Rosetta Genomics (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostic assays, announced that data from a study validating the Company's miRview® lung assay was published in the online edition of the Journal of...
QIAGEN N.V. (NASDAQ: QGEN) today unveiled an advanced initiative to enter the field of next-generation sequencing (NGS) that aims to establish these technologies as routine processes used in new areas such as clinical research and molecular...
Oops! Unable to complete your request. Please refresh your browser.